We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
Cap. Flow
-$488M
Cap. Flow %
-0.46%
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$101M
2
GEV icon
GE Vernova
GEV
+$75.4M
3
CRH icon
CRH
CRH
+$48.5M
4
CRWD icon
CrowdStrike
CRWD
+$45.8M
5
DELL icon
Dell
DELL
+$35.8M

Sector Composition

Rank Sector Weight
1 Technology 30.98%
2 Financials 12.55%
3 Healthcare 11.48%
4 Consumer Discretionary 10.52%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATLO icon
3026
AMES National
ATLO
$277M
$202K ﹤0.01%
9,844
+381
+4% +$7.63K
IHRT icon
3027
iHeartMedia
IHRT
$583M
$201K ﹤0.01%
184,290
+7,258
+4% +$11.3K
INBX icon
3028
Inhibrx
INBX
$1.3B
$201K ﹤0.01%
+14,159
New +$221K
CMCL icon
3029
Caledonia Mining Corp
CMCL
$420M
$200K ﹤0.01%
20,627
+3,795
+23% +$39.1K
WPP icon
3030
WPP
WPP
$5.94B
$199K ﹤0.01%
4,340
-24
-0.5% -$1.19K
AVAH icon
3031
Aveanna Healthcare
AVAH
$2.07B
$197K ﹤0.01%
71,457
+1,114
+2% +$2.78K
ACHV icon
3032
Achieve Life Sciences
ACHV
$683M
$197K ﹤0.01%
+41,818
New +$201K
SWIM icon
3033
Latham Group
SWIM
$880M
$195K ﹤0.01%
64,487
+858
+1% +$2.99K
ALTI icon
3034
AlTi Global
ALTI
$493M
$195K ﹤0.01%
37,443
+19,547
+109% +$94K
CRTO icon
3035
Criteo S.A. Ordinary Shares
CRTO
$923M
$195K ﹤0.01%
5,171
+100
+2% +$3.66K
EVC icon
3036
Entravision Communication
EVC
$1.1B
$195K ﹤0.01%
96,011
+12,880
+15% +$26.7K
MASS icon
3037
908 Devices
MASS
$364M
$194K ﹤0.01%
37,696
-374
-1% -$2.26K
VRCA icon
3038
Verrica Pharmaceuticals
VRCA
$87.3M
$194K ﹤0.01%
2,659
+451
+20% +$34.6K
ARAY icon
3039
Accuray
ARAY
$34M
$193K ﹤0.01%
106,092
+2,219
+2% +$4.23K
GRWG icon
3040
GrowGeneration
GRWG
$90.7M
$193K ﹤0.01%
89,579
+758
+0.9% +$1.92K
CIG icon
3041
CEMIG Preferred Shares
CIG
$6.01B
$192K ﹤0.01%
108,821
-104,531
-49% -$200K
SLDB icon
3042
Solid Biosciences
SLDB
$900M
$191K ﹤0.01%
+33,773
New +$302K
TLYS icon
3043
Tilly's
TLYS
$128M
$191K ﹤0.01%
31,727
-3,158
-9% -$18.3K
HMY icon
3044
Harmony Gold Mining
HMY
$12.3B
$191K ﹤0.01%
20,857
RGCO icon
3045
RGC Resources
RGCO
$228M
$191K ﹤0.01%
9,338
+497
+6% +$10.1K
LSEA
3046
DELISTED
Landsea Homes
LSEA
$191K ﹤0.01%
20,755
+862
+4% +$9.15K
BPRN icon
3047
Princeton Bancorp
BPRN
$287M
$191K ﹤0.01%
5,756
+195
+4% +$5.9K
VIRC icon
3048
Virco
VIRC
$96.3M
$190K ﹤0.01%
+13,664
New +$170K
SERA icon
3049
Sera Prognostics
SERA
$81.1M
$190K ﹤0.01%
+32,166
New +$288K
TTEC icon
3050
TTEC Holdings
TTEC
$124M
$190K ﹤0.01%
32,251
-25,893
-45% -$190K

Similar funds

RhumbLine Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
  • RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
  • RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
  • RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
  • RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.